Diaphragmatic Function as a Biomarker
- Conditions
- FibrosisDyspnea; AsthmaticPulmonary HypertensionDyspneaCOPDAsthma
- Interventions
- Diagnostic Test: Diaphragm UltrasoundDiagnostic Test: Intercostal Muscle UltrasoundDiagnostic Test: Borg scaleDiagnostic Test: MRC Breathlessness ScaleDiagnostic Test: Respiratory QuestionaireDiagnostic Test: GINA classification of AsthmaDiagnostic Test: Measurement of respiratory mouth pressureDiagnostic Test: SNIPDiagnostic Test: 6-minute walking distanceDiagnostic Test: ElectromyographyDiagnostic Test: 60 seconds sit-to-stand testDiagnostic Test: Lung FunctionDiagnostic Test: CAT-QuestionnaireDiagnostic Test: European Society of Cardiology (ESC)/ European Respiratory Society (ERS) risk group
- Registration Number
- NCT05903001
- Lead Sponsor
- RWTH Aachen University
- Brief Summary
Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.
- Detailed Description
The aim of the present project is to comprehensively measure respiratory muscle function and strength in patients with respiratory diseases. The investigators attempt to recruit 800 patients across four disease groups (Asthma, COPD, Fibrosis, and Pulmonary Hypertension) and the investigators intend to measure diaphragm and accessory respiratory muscle function and strength, lung function, and exercise tolerance, as well as the participants' symptom burden during one day at baseline in the investigators' lab. Thereafter, the investigators will follow up on patients by phone 3 months, 6 months, 12 months and 18 months after the investigators have seen them in the investigators' lab. Based on these results, not only the association between dyspnea exercise tolerance and diaphragm function in patients with respiratory diseases can be assessed, but also the prognostic significance of diaphragm dysfunction in these patients can be determined. As such, hospitalization and exacerbation requiring the intake of steroids will be assessed and followed up on by phone, and therefore the prognostic significance of diaphragm dysfunction in predicting hospitalization and the intake of steroids can be determined.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 800
- patient has one of the following lung diseases: COPD, bronchial asthma, pulmonary fibrosis, pulmonary hypertension
- is 18 years or older
- is mentally and physically able to understand the study and to follow instructions
- are legally competent
- signed declaration of consent
- BMI > 35
- current or treatments or diseases in the past which could influence the evaluation of the study
- Expected lack of willingness to actively participate in study-related measures
- alcohol or drug abuse
- disc herniation/prolapse
- epilepsy
- wheelchair bound
- in custody due to an official or court order
- in a dependent relationship or employment relationship with investigating physician or one of their deputy
- emergency inpatient hospital stay within 4 weeks before study-specific examinations
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with Fibrosis Borg scale - Patients with Fibrosis Lung Function - Patients with Asthma GINA classification of Asthma - Patients with COPD Diaphragm Ultrasound - Patients with COPD Intercostal Muscle Ultrasound - Patients with Fibrosis Intercostal Muscle Ultrasound - Patients with Fibrosis MRC Breathlessness Scale - Patients with Fibrosis Electromyography - Patients with Pulmonary Hypertension Borg scale - Patients with Pulmonary Hypertension MRC Breathlessness Scale - Patients with Asthma Diaphragm Ultrasound - Patients with Asthma Borg scale - Patients with Asthma 6-minute walking distance - Patients with COPD 6-minute walking distance - Patients with COPD CAT-Questionnaire - Patients with Asthma Respiratory Questionaire - Patients with Asthma Measurement of respiratory mouth pressure - Patients with Asthma SNIP - Patients with Asthma 60 seconds sit-to-stand test - Patients with Asthma Electromyography - Patients with Asthma Lung Function - Patients with COPD Lung Function - Patients with Fibrosis Respiratory Questionaire - Patients with Fibrosis SNIP - Patients with Asthma Intercostal Muscle Ultrasound - Patients with Asthma MRC Breathlessness Scale - Patients with COPD Borg scale - Patients with COPD MRC Breathlessness Scale - Patients with COPD Measurement of respiratory mouth pressure - Patients with COPD 60 seconds sit-to-stand test - Patients with Pulmonary Hypertension Intercostal Muscle Ultrasound - Patients with Pulmonary Hypertension SNIP - Patients with Fibrosis 6-minute walking distance - Patients with COPD Electromyography - Patients with Fibrosis Diaphragm Ultrasound - Patients with Pulmonary Hypertension Respiratory Questionaire - Patients with Pulmonary Hypertension 6-minute walking distance - Patients with Pulmonary Hypertension Electromyography - Patients with COPD Respiratory Questionaire - Patients with COPD SNIP - Patients with Fibrosis Measurement of respiratory mouth pressure - Patients with Fibrosis 60 seconds sit-to-stand test - Patients with Pulmonary Hypertension Lung Function - Patients with Pulmonary Hypertension Diaphragm Ultrasound - Patients with Pulmonary Hypertension Measurement of respiratory mouth pressure - Patients with Pulmonary Hypertension European Society of Cardiology (ESC)/ European Respiratory Society (ERS) risk group - Patients with Pulmonary Hypertension 60 seconds sit-to-stand test -
- Primary Outcome Measures
Name Time Method Dyspnea Borg scale 1 to 10 follow up 18 months after recruitment Borg scale before and after "6 minute walking distance" test. Lower scores show fewer dyspnea, higher scores indicate more dyspnea.
- Secondary Outcome Measures
Name Time Method Blood Gas Analysis 6 months recruiting pH scale
Sit-to stand-test (60 seconds) 6 months recruiting Measurement of achieved repetitions of standing up and sitting down from an initial seated position in 60 seconds.
New York Heart Association (NYHA) classification scale 1 to 4 6 months recruiting, follow up up to 18 months after last recruitment Patients are linked to a NYHA degree. Lower scores show fewer dyspnea, higher scores indicate more dyspnea.
Modified Medical Research Council (MRC) Breathlessness Scale 1 to 5 6 months recruiting, follow up up to 18 months after last recruitment Patients are assessed and grouped according to their MRC Breathlessness Scale. Lower scores show fewer dyspnea, higher scores indicate more dyspnea.
COPD Assessment Test (CAT-Questionnaire) from 0 to 40 points. 6 months recruiting, follow up up to 18 months after last recruitment Patients are evaluated and placed into the corresponding groups. Lower scores show fewer dyspnea, higher scores indicate more dyspnea.
Diaphragm Thickening Ratio (DTR) in percent 6 months recruiting Via ultrasound, the diaphragm thickening ratio (DTR) was calculated as thickness at total lung capacity (TLC) divided by thickness at functional residual capacity (FRC).
Diaphragm ultrasound sniff velocity in cm/s 6 months recruiting Via ultrasound, the diaphragm sniff velocity was assessed during tidal breathing and following a maximum sniff.
Blood Gas Analysis in cmH2O 6 months recruiting carbon dioxide partial pressure (pCO2)
6 minute walking distance in m 6 months recruiting Measurement of achieved walking distance in 6 minutes
Chronic Respiratory Questionnaire (CRQ) 6 months recruiting, follow up up to 18 months after last recruitment Assessments of different domains (Emotional Domain, Dyspnea Domain, Mastery Domain, Fatigue Domain) in a standardized questionnaire on a scale from 1 to 7. The scores for each question of each dimension are added together and divided by the number of completed questions in each domain. In general, higher scores mean a worse outcome and lower scores mean a better outcome.
For the dyspnea domain for example, a high score means that patients have less dyspnea, and a low score means that patients have more dyspnea.Body Plethysmography 6 months recruiting TLC (Total lung capacity) in percent predicted.
Diaphragm thickness at functional capacity (FRC) 6 months recruiting Via ultrasound, the diaphragm thickness at FRC is measured after a normal expiration.
Global Initiative for Asthma (GINA) classification 6 months recruiting, follow up up to 18 months after last recruitment Patients are assessed and grouped as mild, moderate, or severe according to the GINA classification.
Diaphragm thickness at Total lung capacity (TLC) 6 months recruiting Via ultrasound, the diaphragm thickness at TLC is measured at the maximum point of inspiration.
Intercostal Muscle ultrasound thickness at Total lung capacity (TLC) in cm 6 months recruiting Via ultrasound, the intercostal thickness at TLC is measured at the maximum point of inspiration.
Intercostal Muscle ultrasound thickness at functional capacity (FRC) in cm 6 months recruiting Via ultrasound, the intercostal thickness at FRC is measured after a normal expiration.
Intercostal Muscle Thickening Ratio in percent 6 months recruiting Via ultrasound, the intercostal muscle thickening ratio was calculated as thickness at total lung capacity (TLC) divided by thickness at functional residual capacity (FRC).
Maximum Inspiratory Pressure (MIP) in percent predicted 6 months recruiting Measurement of Maximum Inspiratory Pressure
Maximum Expiratory Pressure (MEP) in percent predicted 6 months recruiting Measurement of Maximum Expiratory Pressure
Sniff Nasal Inspiratory Pressure (SNIP) in percent predicted 6 months recruiting Measurement of Sniff Nasal Inspiratory Pressure
Blood Gas Analysis in mmol/l 6 months recruiting Base Excess
Electromyography (EMG) 6 months recruiting Measurement of electrical activity during different breathing maneuvers (Sniff, Cough, Valsalva, Mueller) via superficial electrodes placed on the diaphragm and accessory respiratory muscles (Sternocleidomastoideus muscle, intercostal muscles).
Blood Gas Analysis in (I1/s) percent 6 months recruiting Base Excess
Trial Locations
- Locations (1)
RWTH Aachen University Hospital
🇩🇪Aachen, North Rhine-westphalia, Germany